Global

South Sudanese patients wait for medical treatment in the outpatient department of a medical camp.
Photograph: AFP/Getty Images

Oxfam’s water and sanitation coordinator writes about the challenges of bringing South Sudan’s cholera outbreak under control

theguardian.com - by Katrice King - August 6, 2015

“I have no money to continue buying water. I will have to beg from those at the borehole or from the water trucks. Or else, I go back to the village,” a mother of five told me recently. . . .

. . . This is the agonising reality of families I have met in parts of Juba; they are struggling to cope with a worsening water crisis fuelled by the deteriorating economic situation in South Sudan. As a result, the city is now left exposed to the spread of deadly diseases.

Cholera has already claimed 42 lives since May – including seven children – and has infected more than 1,400 people. . . .

. . . If the water shortages continue, hygiene conditions in the most affected areas will worsen and people will have no alternative but to use unprotected sources such as rivers and open wells, exposing more people to cholera.

Image: Chart showing temperature, dew point in index in Bandar Mahshahr over last 36 hours, using National Weather Service heat index value calculations. (Brian McNoldy)

washingtonpost.com - July 31st, 2015 - Jason Samenow

Wherever you live or happen to travel to, never complain about the heat and humidity again.

In the city of Bandar Mahshahr (population of about 110,000 as of 2010), the air felt like a searing 165 degrees (74 Celsius) today factoring in the humidity.

Although there are no official records of heat indices, this is second highest level we have ever seen reported.

(VIEW COMPLETE ARTICLE)

Analysis
WIRED.COM by Katie M. Palmer                                                            Aug. 4, 2015

Last week, the medical journal the Lancet published preliminary results on the efficacy of an Ebola vaccine in Guinea, and everybody got really excited—especially about one particular figure. The vaccine, the results suggested, was 100 percent effective at protecting against Ebola, a thrilling prospect in the face of an epidemic that has killed more than 11,000 people. ...

But that number probably means less than you think it does. It’s based on incomplete data, so it doesn’t have the statistical clout it should. And it never will. Based on the vaccine’s early success, the trial’s runners decided that all participants in the study should get it immediately after exposure. That’s a perfectly reasonable, humane reaction, but it also means that the researchers will never be able to collect better data on the vaccine’s efficacy, which is what regulators look for when they’re deciding to approve a drug. In other words, the vaccine’s early success could make it harder for people to get it down the line.

nam.edu - July 29, 2015

The first meeting of the Commission on a Global Health Risk Framework for the Future took place on July 28-29, 2015 at the National Academy of Sciences building, located at 2101 Constitution Avenue, NW, in Washington, DC. The meeting was closed on July 28, but open to the public on July 29 from 9 am to 1 pm.

The objectives of the open session on July 29 included the following:

The International Oversight Group will present the Statement of Task to the Commission and make clarifications, if needed.

An expert panel will address issues of governance, finance, resilient health systems, and medical products research and development when responding to infectious disease outbreaks of international concern at the global, regional, national, and local levels. The Commission will consider the different perspectives presented, as they develop the approach for this study.

(CLICK HERE FOR ADDITIONAL INFORMATION)